Market Snapshot and Forecast with the Impact of COVID-19



Summary The global active pharmaceutical ingredients (API) market was valued at USD 179.6 billion in 2020. Growth opportunities for the active pharmaceutical ingredients market are attributed to growing geriatric population, increasing technical advancements, ‘Increase in API manufacturing facilities globally and an increasing number of research and development activities carried out by some of the major players in the global platform market.

New York, January 07, 2022 (GLOBE NEWSWIRE) – Announces the Publication of the “Global Active Pharmaceutical Ingredients Market – Drug Type Analysis, Summary, Application, Region, Country: Market Overview and Forecast with the impact of COVID-19 “-

In addition, the growing awareness, along with investment in the development of new drugs in the market, is increasing the number of clinical trials around the world, which is driving the market for active pharmaceutical ingredients. With the increasing prevalence of respiratory diseases due to the COVID-19 outbreak, it is expected that there will be more demand for new drugs, which is likely to push the demand for APIs and hence to affect the global active pharmaceuticals market in the world.

Biopharmaceutical companies are opting for mergers and acquisitions to access new technologies, expand their market area and increase their capital for clinical trials and investments. The API market has experienced impressive growth in recent years. This growth trend is expected to continue due to increased demand from the Asia-Pacific region in the future. This is mainly due to China, India and Japan which consist of huge population and hence huge incidence of infectious diseases requiring drugs for treatment.

In addition, the growing number of deaths and the spread of the virus have prompted many pharmaceutical companies, biopharmaceutical companies and small start-ups to collaborate and come up with effective drugs to combat it. Scientists around the world have found molecules capable of effectively targeting COVID-19. Currently, 155 molecules are under clinical investigation and 45 molecules are under preclinical development to target COVID-19. Companies are monitored locally to protect the safety of study participants, staff, and employees during these times.

Scope of the report
• The report analyzes the Active Pharmaceutical Ingredients Market by Value (Billion USD)

• The report analyzes the Active Pharmaceutical Ingredients Market by Application (Oncology, Cardiology, Diabetes, Neurology, Others).

• The report analyzes the market of active pharmaceutical ingredients by drug type (generic API, innovative API)

• The report analyzes the active pharmaceutical ingredients market by synthesis (synthetic, biotechnology)

• The global active pharmaceutical ingredients market has been analyzed by region (North America, Europe, Asia-Pacific, LAMEA).

• The global market for active pharmaceutical ingredients was analyzed by country (United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India).

• The attractiveness of the market was presented by region, by application, by type of drug and by synthesis.

• In addition, the major opportunities, trends, drivers and challenges of the industry have been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions, and new product development.

• Companies analyzed in the report include Pfizer Inc., GlaxoSmithKline, AbbVie Inc., Novartis AG, Eli Lilly and Company, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sanofi, Bristol-Myers Squibb and Boehringer Ingelheim.

• The report presents the analysis of the active pharmaceutical ingredients market for the historical period of 2016-2020 and the forecast period of 2021-2026.

Key target audience

• Manufacturers of active pharmaceutical ingredients

• Pharmaceutical companies

• Consulting and consulting firms

• Government and decision-makers

• Regulatory authorities
Read the full report:

About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001



Comments are closed.